← Back to Clinical Trials
Recruiting NCT06989385

NCT06989385 CORALINE - Correlation Between Physiological and Clinical Variables and Failure of Non-Invasive Respiratory Support in Patients With Acute Respiratory Failure

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06989385
Status Recruiting
Phase
Sponsor University of Modena and Reggio Emilia
Condition Acute Respiratory Failure
Study Type OBSERVATIONAL
Enrollment 325 participants
Start Date 2024-11-01
Primary Completion 2028-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
This is an observational study. Interventions are standard of care and include: High-flow nasal oxygen (HFNO) Non-invasive ventilation (NIV) Pnose monitoring

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 325 participants in total. It began in 2024-11-01 with a primary completion date of 2028-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to evaluate the relationship between clinical and physiological variables and the failure of non-invasive respiratory support (NIRS), including high-flow nasal oxygen (HFNO) and non-invasive ventilation (NIV), in patients with acute respiratory failure (ARF), both hypoxemic and/or hypercapnic. The study includes both retrospective and prospective components. Retrospective data will be collected from patient charts, while prospective data will be collected at defined time points during clinical care. The primary outcome is NIRS failure, defined as the need for orotracheal intubation. Secondary outcomes include in-hospital and 90-day mortality, ICU and hospital length of stay, and duration of non-invasive and invasive support.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years * Hospitalization in the Respiratory Medicine Unit at AOU Policlinico di Modena * Acute respiratory failure (hypoxemic and/or hypercapnic) with PaO₂/FiO₂ \< 300 mmHg * Undergoing treatment with HFNO or NIV Exclusion Criteria: * Immediate need for invasive ventilation upon admission * Known neuromuscular disease * Pregnancy * Lack of informed consent

Contact & Investigator

Central Contact

Roberto Tonelli, MD, PhD

✉ rtonelli@unimore.it

📞 +390594225934

Frequently Asked Questions

Who can join the NCT06989385 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Respiratory Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06989385 currently recruiting?

Yes, NCT06989385 is actively recruiting participants. Contact the research team at rtonelli@unimore.it for enrollment information.

Where is the NCT06989385 trial being conducted?

This trial is being conducted at Modena, Italy.

Who is sponsoring the NCT06989385 clinical trial?

NCT06989385 is sponsored by University of Modena and Reggio Emilia. The trial plans to enroll 325 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology